Valuation : Consort Medical plc

Market Cap 502M 432M 406M 371M 694M 47.39B 696M 4.8B 1.86B 24.31B 1.88B 1.84B 78.33B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 516M 485M 443M 829M 56.59B 831M 5.73B 2.22B 29.03B 2.25B 2.2B 93.53B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 01/02/2023
Director/Board Member 52 01/04/2024
Director/Board Member 53 01/04/2024
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/20 A Sell 211,474 0.4284%
2/6/20 A Exercice 211,474 0.4284%
2/6/20 A Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
-0.42%-3.68%-18.51%+6.67% 187B
+1.15%+3.22%+1.37%+16.68% 120B
-1.86%+2.77%+13.15%+89.47% 63.15B
-0.33%-2.20%+15.92%+49.39% 51.75B
-1.54%-2.52%-3.98%-30.72% 50.32B
-2.02%-3.22%+9.18%-17.76% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-16.03% 23.93B
-1.81%-5.09%-10.14%+8.89% 22.99B
Average -0.76%-0.38%+5.32%+13.33% 58.59B
Weighted average by Cap. -0.48%-0.64%-1.68%+16.54%

Financials

2018 2019
Net sales 311M 268M 252M 230M 430M 29.37B 432M 2.98B 1.15B 15.07B 1.17B 1.14B 48.55B 305M 263M 247M 226M 422M 28.81B 423M 2.92B 1.13B 14.78B 1.15B 1.12B 47.61B
Net income 16.1M 13.85M 13.03M 11.91M 22.27M 1.52B 22.34M 154M 59.77M 780M 60.46M 59.14M 2.51B 10.5M 9.04M 8.5M 7.77M 14.53M 991M 14.57M 100M 38.98M 509M 39.43M 38.57M 1.64B
Net Debt 95.5M 82.18M 77.32M 70.63M 132M 9.02B 132M 914M 355M 4.63B 359M 351M 14.9B 97.4M 83.81M 78.86M 72.04M 135M 9.2B 135M 932M 362M 4.72B 366M 358M 15.2B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!